Your fibromyalgia isn't just in your head. Your genes may be programming it.

COMT is an enzyme that breaks down catecholamines, the stress hormones dopamine, norepinephrine, and epinephrine. This is a critical cleanup job. When your COMT works efficiently, stress hormones are cleared within milliseconds, allowing your nervous system to return to baseline. When stress hormones linger, your nervous system stays in a heightened, reactive state.

The Val158Met variant is found in roughly 25% of people in European ancestry populations. The Met allele (slow variant) reduces COMT enzyme activity by 3-4 fold. This means dopamine, norepinephrine, and epinephrine hang around in your synapses far longer than they should. Your nervous system stays physiologically activated and pain-sensitized even when no actual threat exists. You feel constantly on edge. Your pain threshold drops. Every sensation feels amplified.

If you have slow COMT, you’re more vulnerable to sensory overload, noise sensitivity, light sensitivity, and emotional reactivity. Your muscles stay slightly tense because your sympathetic nervous system never fully downregulates. Pain that would be minor in someone with fast COMT feels significant to you. Stress doesn’t just cause emotional discomfort; it directly amplifies your fibromyalgia.

BDNF is brain-derived neurotrophic factor, a protein that supports the survival and growth of neurons and also modulates synaptic plasticity. In pain circuits specifically, BDNF helps your brain learn to downregulate pain signals and to limit central sensitization. Central sensitization is the hallmark of fibromyalgia: a process where your spinal cord and brain amplify pain signals disproportionately so that minor inputs produce major pain outputs.

The Val66Met variant, carried by roughly 30% of the population, reduces BDNF secretion in response to neuronal activity. Your pain-regulating circuits are less plastic and less capable of learning to suppress pain signals. Once central sensitization begins, it’s harder for your nervous system to reverse it. You’re stuck in a state of amplified pain processing.

With a Val66Met BDNF variant, you may notice that pain doesn’t improve as quickly as you expect even when the triggering event resolves. You develop a lower pain threshold over time. Minor injuries or illnesses can trigger disproportionate pain that persists long after they should have healed. Your nervous system struggles to plastically relearn that certain stimuli are safe.

SLC6A4 encodes the serotonin transporter, the protein that recycles serotonin back into the neuron after it’s been released. Serotonin is critical for pain inhibition. Descending pain-suppressing pathways in the brainstem release serotonin onto the spinal cord, where it dampens incoming pain signals. Without adequate serotonin availability, this natural pain-suppressing system fails.

The 5-HTTLPR short allele, found in roughly 40% of the population, reduces the efficiency of serotonin reuptake. Less serotonin stays available in the synapse to activate pain-suppressing receptors. Your natural braking system for pain is weaker. You’re more reactive to painful stimuli and more vulnerable to chronic pain development.

If you carry one or two short alleles, you likely notice that pain feels more intrusive and harder to manage mentally. Stress worsens your fibromyalgia more dramatically than it does in people with long alleles. Sleep disruption (which lowers serotonin) makes pain significantly worse. You may be more vulnerable to mood symptoms like anxiety or low mood alongside your pain, because the same serotonin insufficiency drives both.

TRPV1 is a receptor on the surface of pain-sensing neurons. It detects heat, chemical irritants, and other painful stimuli. TRPV1 is one of the primary molecular channels that allows nociceptive (pain) signals to fire. When TRPV1 is hyperactive, these pain neurons fire too easily, even at mild stimuli. When it’s underactive, pain signals are suppressed.

Variants in TRPV1, found in roughly 25-30% of the population, often result in gain-of-function effects: the receptor becomes more sensitive to stimuli. Your pain-sensing neurons fire at lower thresholds, so pressure, temperature, and chemical signals all feel more painful. You have a lower intrinsic pain tolerance at the peripheral nervous system level.

With a gain-of-function TRPV1 variant, you may notice that light touch or pressure that doesn’t bother others feels uncomfortable. You’re sensitive to temperature extremes (hot baths or cold weather hurt more). You experience allodynia, where normally non-painful stimuli feel painful. Your muscles feel tender to pressure. Even gentle massage can feel irritating rather than soothing.

MTHFR encodes methylenetetrahydrofolate reductase, the enzyme that converts dietary folate into its active form, methylfolate. Methylfolate is the critical substrate for methylation reactions throughout your body and brain, including the synthesis of serotonin, dopamine, and norepinephrine. It’s also essential for reducing homocysteine levels and supporting immune regulation.

The C677T variant, carried by roughly 40% of people in European ancestry populations, reduces MTHFR enzyme activity by 40-70%. Your cells struggle to convert folate into its active methylated form, even if you eat plenty of folate-rich foods. You develop a functional folate deficiency at the cellular level. This impairs neurotransmitter synthesis and leaves homocysteine elevated, both of which increase pain sensitivity and reduce pain tolerance.

With MTHFR C677T, you may find that standard B vitamins don’t help your energy, mood, or pain levels because your body can’t utilize them efficiently. You might have elevated homocysteine (which increases inflammation and excitotoxicity in pain circuits). Your serotonin and dopamine systems run on reserve. Adding stress or illness depletes them further, worsening fibromyalgia symptoms. You may notice that your pain and fatigue cluster together.

OPRM1 encodes the mu-opioid receptor, the target for endogenous opioids like endorphins and enkephalins. These are your body’s own pain-suppressing molecules. When you exercise, laugh, or experience pleasure, your brain releases endogenous opioids that activate mu-opioid receptors, suppressing pain. This is a crucial pain-management system that works 24/7.

The A118G variant (G allele), found in roughly 10-15% of European ancestry populations, reduces the receptor’s sensitivity to endogenous opioids. Your natural opioid signaling is blunted; your body produces the pain-relieving molecules, but your receptors don’t respond to them as strongly. Your intrinsic analgesic capacity is reduced. You have a naturally lower pain threshold and fewer internal tools to suppress chronic pain.

If you carry the G allele, you may notice that exercise, which is supposed to boost endorphins and relieve pain, helps you less than it helps others. Laughter and joy provide less pain relief. You may feel more vulnerable to pain amplification. Your pain doesn’t respond as well to your own internal pain-management efforts. You may also have a weaker response to external opioid medications if you ever need them, though the primary issue is your baseline pain tolerance.